MedPath

NOVO-WARFARIN

NOVO-WARFARIN

Discontinued
DIN Number

02265311

Drug Class

Human

Market Date

Feb 23, 2005

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02265311
AIG Number0104597007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AA03 WARFARIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

WARFARIN SODIUMActive
Strength: 3 MG
Monograph: WARFARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.